Delcath Systems (DCTH) EBITDA Margin Growth (1y) (2013 - 2026)
Delcath Systems (DCTH) EBITDA Margin Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 102.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 58.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 851.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -313.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 535.00 |
| 10 | Delcath Systems | 420.91 Mn | 331.59 Mn | 21.26 Mn | -1,121.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,121.00 |
| Dec 31, 2025 | 1,144.00 |
| Sep 30, 2025 | -1,126.00 |
| Jun 30, 2025 | 19,089.00 |
| Mar 31, 2025 | 36,018.00 |
| Dec 31, 2024 | 200,802.00 |
| Sep 30, 2024 | 470,215.00 |
| Jun 30, 2024 | 127,609.00 |
| Mar 31, 2024 | 115,109.00 |
| Dec 31, 2023 | -73,287.00 |
| Sep 30, 2023 | -370,061.00 |
| Jun 30, 2023 | -17,640.00 |
| Mar 31, 2023 | 87,607.00 |
| Dec 31, 2022 | -108,491.00 |
| Sep 30, 2022 | 458,520.00 |
| Jun 30, 2022 | 35,236.00 |
| Mar 31, 2022 | 16,862.00 |
| Dec 31, 2021 | 68,357.00 |
| Sep 30, 2021 | -152,722.00 |
| Jun 30, 2021 | 116.00 |